Neu­triSci talks CBD tablet li­cens­ing deal with LaSanta

Stockwatch Daily - - HEALTH CARE - Mr. Glen Rehman re­ports

NEU­TRISCI IN­TER­NA­TIONAL Inc. has en­tered into a mem­o­ran­dum of un­der­stand­ing out­lin­ing the terms for the man­u­fac­tur­ing and distri­bu­tion of sub­lin­gual cannabid­iol (CBD) tablets, based on Neu­triSci’s pro­pri­etary sub­lin­gual tablet for­mu­la­tions, with LaSanta Botan­i­cals Ltd., a pri­vately held com­pany based in Cal­gary, Alta., with op­er­a­tions in Bo­gota, Colom­bia. The li­censee is li­censed in Colom­bia to cul­ti­vate cannabis and to man­u­fac­ture and ex­port cannabis ex­tracts.

Sub­ject to the terms out­lined in the MOU, Neu­triSci will pro­vide the li­censee with ex­clu­sive rights for Mex­ico, Cen­tral Amer­ica and South Amer­ica to uti­lize the Neu­triSci tech­nolo­gies such that the li­censee can pro­duce and mar­ket sub­lin­gual CBD tablets. The tablets are a quick dis­solv­ing, flavoured tablet that of­fer a method to pro­vide the con­sumer with a mea­sured dose of known CBD prod­uct.

Upon sign­ing of a de­fin­i­tive agree­ment, the li­censee will pay Neu­triSci a one-time li­cens­ing fee and quar­terly roy­al­ties based on the value of each unit sold. The li­censee in­tends to mar­ket the prod­uct within its own net­work as well as through third party dis­trib­u­tors. As part of the MOU, the li­censee may also sup­ply Neu­triSci with CBD when all le­gal re­quire­ments are met.

Neu­triSci chief ex­ec­u­tive of­fi­cer Glen Rehman stated: “This MOU es­tab­lishes the next in­ter­na­tional prod­uct man­u­fac­tur­ing and distri­bu­tion deal uti­liz­ing our patent pend­ing tech­nolo­gies. To­gether with the li­censee, we are very ex­cited to be work­ing to­wards launch­ing the first of its kind quick dis­solv­ing CBD tablet in South Amer­ica. This agree­ment rep­re­sents an­other step to­wards achiev­ing the in­ter­na­tional distri­bu­tion of our prod­ucts and IP. Neu­triSci is also ex­cited that once all le­gal re­quire­ments are met it will be able to ac­cess low-cost, high-qual­ity CBD com­pounds for distri­bu­tion with its global part­ners.”

About Neu­triSci In­ter­na­tional Inc.

Neu­triSci In­ter­na­tional spe­cial­izes in the in­no­va­tion, pro­duc­tion and for­mu­la­tion of nu­traceu­ti­cal prod­ucts. Es­tab­lished in 2009, Neu­triSci In­ter­na­tional is build­ing sus­tain­able sales mod­els with con­ve­nience, chain drug, and mass mar­ket and su­per­mar­ket re­tail­ers for neuen­ergy, the com­pany’s nat­u­ral en­ergy and fo­cus sup­ple­ment that has at its core, the ben­e­fi­cial ef­fects of blue­ber­ries.

We seek Safe Har­bor.

Jef­frey Wayne Durno, An­thony Hu­gens, Dana Mon­tene­gro, Glen Rehman

(NU) Shares: 114,630,100

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.